NURO NeuroMetrix Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NURO

Price (delayed)

$4.44

Market cap

$8.82M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.27

Enterprise value

$7.33M

NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of disorders involving the nervous system. The Company has ...

Highlights
NeuroMetrix's debt has decreased by 32% YoY and by 11% QoQ
NURO's quick ratio is down by 24% year-on-year but it is up by 3% since the previous quarter
NURO's net income is down by 48% YoY and by 17% QoQ
NeuroMetrix's gross profit has decreased by 31% YoY and by 9% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.neurometrix.com
Peers: IART SYK MDT

Key stats

What are the main financial stats of NURO
Market
Shares outstanding
1.99M
Market cap
$8.82M
Enterprise value
$7.33M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.24
Price to sales (P/S)
0.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.24
Earnings
Revenue
$5.9M
EBIT
-$6.53M
EBITDA
-$6.47M
Free cash flow
-$6.27M
Per share
EPS
-$6.27
Free cash flow per share
-$5.84
Book value per share
$18.71
Revenue per share
$5.5
TBVPS
$19.95
Balance sheet
Total assets
$21.42M
Total liabilities
$1.33M
Debt
$240,876
Equity
$20.09M
Working capital
$19.61M
Liquidity
Debt to equity
0.01
Current ratio
16.81
Quick ratio
14.92
Net debt/EBITDA
0.23
Margins
EBITDA margin
-109.7%
Gross margin
66.9%
Net margin
-110.6%
Operating margin
-121.2%
Efficiency
Return on assets
-29.3%
Return on equity
-31.3%
Return on invested capital
-33.6%
Return on capital employed
-32.4%
Return on sales
-110.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NURO stock price

How has the NeuroMetrix stock price performed over time
Intraday
0.68%
1 week
3.26%
1 month
9.63%
1 year
-60.5%
YTD
23.33%
QTD
4.96%

Financial performance

How have NeuroMetrix's revenue and profit performed over time
Revenue
$5.9M
Gross profit
$3.95M
Operating income
-$7.15M
Net income
-$6.53M
Gross margin
66.9%
Net margin
-110.6%
NURO's operating margin has shrunk by 111% YoY and by 27% QoQ
NeuroMetrix's net margin has shrunk by 107% YoY and by 28% QoQ
NURO's operating income has dropped by 51% year-on-year and by 16% since the previous quarter
NURO's net income is down by 48% YoY and by 17% QoQ

Growth

What is NeuroMetrix's growth rate over time

Valuation

What is NeuroMetrix stock price valuation
P/E
N/A
P/B
0.24
P/S
0.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.24
NURO's EPS is down by 26% YoY and by 13% QoQ
The P/B is 78% below the 5-year quarterly average of 1.1 and 20% below the last 4 quarters average of 0.3
The equity has declined by 14% year-on-year
The stock's price to sales (P/S) is 55% less than its 5-year quarterly average of 1.8 and 19% less than its last 4 quarters average of 1.0
NURO's revenue is down by 29% year-on-year and by 8% since the previous quarter

Efficiency

How efficient is NeuroMetrix business performance
NURO's ROS has shrunk by 107% YoY and by 28% QoQ
NURO's ROA has plunged by 66% YoY and by 22% from the previous quarter
NeuroMetrix's ROE has plunged by 65% YoY and by 22% from the previous quarter
The ROIC has contracted by 18% from the previous quarter and by 14% YoY

Dividends

What is NURO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NURO.

Financial health

How did NeuroMetrix financials performed over time
NURO's quick ratio is down by 24% year-on-year but it is up by 3% since the previous quarter
The current ratio has contracted by 23% YoY but it has grown by 2.3% from the previous quarter
NeuroMetrix's debt is 99% lower than its equity
NURO's debt to equity has dropped by 50% year-on-year
NeuroMetrix's debt has decreased by 32% YoY and by 11% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.